| Proteogenomics connects somatic mutations to signalling in breast cancer P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ... Nature 534 (7605), 55-62, 2016 | 1574 | 2016 |
| Role of accurate mass measurement (±10 ppm) in protein identification strategies employing MS or MS/MS and database searching KR Clauser, P Baker, AL Burlingame Analytical chemistry 71 (14), 2871-2882, 1999 | 1458 | 1999 |
| MitoCarta2. 0: an updated inventory of mammalian mitochondrial proteins SE Calvo, KR Clauser, VK Mootha Nucleic acids research 44 (D1), D1251-D1257, 2016 | 1371 | 2016 |
| Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule BC Cunningham, M Ultsch, AM de Vos, MG Mulkerrin, KR Clauser, ... Science 254 (5033), 821-825, 1991 | 1275 | 1991 |
| The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices A Naba, KR Clauser, S Hoersch, H Liu, SA Carr, RO Hynes Molecular & Cellular Proteomics 11 (4), 2012 | 1185 | 2012 |
| The extracellular matrix: Tools and insights for the “omics” era A Naba, KR Clauser, H Ding, CA Whittaker, SA Carr, RO Hynes Matrix Biology 49, 10-24, 2016 | 953 | 2016 |
| De Novo Peptide Sequencing via Tandem Mass Spectrometry V Dančík, TA Addona, KR Clauser, JE Vath, PA Pevzner Journal of computational biology 6 (3-4), 327-342, 1999 | 815 | 1999 |
| Integrated proteomic analysis of post-translational modifications by serial enrichment P Mertins, JW Qiao, J Patel, ND Udeshi, KR Clauser, DR Mani, ... Nature methods 10 (7), 634-637, 2013 | 659 | 2013 |
| Repeatability and reproducibility in proteomic identifications by liquid chromatography− tandem mass spectrometry DL Tabb, L Vega-Montoto, PA Rudnick, AM Variyath, AJL Ham, DM Bunk, ... Journal of proteome research 9 (2), 761-776, 2010 | 635 | 2010 |
| Mass spectrometry profiling of HLA-associated peptidomes in mono-allelic cells enables more accurate epitope prediction JG Abelin, DB Keskin, S Sarkizova, CR Hartigan, W Zhang, J Sidney, ... Immunity 46 (2), 315-326, 2017 | 597 | 2017 |
| Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities S Vasaikar, C Huang, X Wang, VA Petyuk, SR Savage, B Wen, Y Dou, ... Cell 177 (4), 1035-1049. e19, 2019 | 595 | 2019 |
| The need for guidelines in publication of peptide and protein identification data: Working Group on Publication Guidelines for Peptide and Protein Identification Data S Carr, R Aebersold, M Baldwin, AL Burlingame, K Clauser, A Nesvizhskii Molecular & Cellular Proteomics 3 (6), 531-533, 2004 | 583 | 2004 |
| Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ... Cell 182 (1), 200-225. e35, 2020 | 493 | 2020 |
| A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages H Lu, KR Clauser, WL Tam, J Fröse, X Ye, EN Eaton, F Reinhardt, ... Nature cell biology 16 (11), 1105-1117, 2014 | 451 | 2014 |
| Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters A Naba, KR Clauser, JM Lamar, SA Carr, RO Hynes elife 3, e01308, 2014 | 438 | 2014 |
| Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography–mass spectrometry P Mertins, LC Tang, K Krug, DJ Clark, MA Gritsenko, L Chen, KR Clauser, ... Nature protocols 13 (7), 1632-1661, 2018 | 409 | 2018 |
| Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels P Mertins, F Yang, T Liu, DR Mani, VA Petyuk, MA Gillette, KR Clauser, ... Molecular & cellular proteomics 13 (7), 1690-1704, 2014 | 400 | 2014 |
| A large peptidome dataset improves HLA class I epitope prediction across most of the human population S Sarkizova, S Klaeger, PM Le, LW Li, G Oliveira, H Keshishian, ... Nature biotechnology 38 (2), 199-209, 2020 | 397 | 2020 |
| Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy K Krug, EJ Jaehnig, S Satpathy, L Blumenberg, A Karpova, M Anurag, ... Cell 183 (5), 1436-1456. e31, 2020 | 338 | 2020 |
| Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis H Liao, J Wu, E Kuhn, W Chin, B Chang, MD Jones, S O'Neil, KR Clauser, ... Arthritis & Rheumatism 50 (12), 3792-3803, 2004 | 332 | 2004 |
D R ManiBroad Institute of MIT and Harvard在 broadinstitute.org 的电子邮件经过验证
